Reuters logo
BRIEF-Nicox gets letter from FDA related to GMP on NDA for AC-170
October 11, 2016 / 12:17 AM / a year ago

BRIEF-Nicox gets letter from FDA related to GMP on NDA for AC-170

Oct 10 (Reuters) - Nicox Sa

* Nicox receives complete response letter from the FDA related to GMP on NDA for ac-170

* Nicox sa - crl did not include any concerns related to finished product manufacturing facility

* Nicox sa - since receipt of crl, nicox has been contacting its suppliers to assess timeline for api manufacturer to address fda’s concerns

* Nicox sa - once issues have been addressed, nicox will then resubmit ac-170 nda

* Nicox sa - fda’s stated reason for crl pertains solely to a good manufacturing practice (gmp) inspection at a third party facility Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below